[Form 4] SHERWIN WILLIAMS CO Insider Trading Activity

Rhea-AI Filing Summary

Sherwin-Williams (SHW) reported an insider equity grant. The company’s President & CEO, who is also a director, received 47,630 employee stock options on October 20, 2025 at an exercise price of $331.37 per share. These options expire on October 19, 2035 and vest in three substantially equal annual installments beginning October 20, 2026, pursuant to the 2025 Equity and Incentive Compensation Plan. No open-market stock sales or purchases were reported.

Insights

Equity compensation analyst

Routine CEO option grant; non-cash, neutral impact.

The filing records a grant of 47,630 employee stock options with a strike price of $331.37, awarded on October 20, 2025 under the 2025 Equity and Incentive Compensation Plan. Options vest in three substantially equal tranches starting October 20, 2026 and expire on October 19, 2035.

This is standard executive compensation and does not involve an immediate share issuance or cash movement. Any eventual share delivery would depend on future vesting and exercise decisions.

No open‑market transactions were disclosed in this report. Future ownership changes, if any, would occur upon vesting and exercise under plan terms.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Petz Heidi G

(Last) (First) (Middle)

101 W. PROSPECT AVENUE

(Street)

CLEVELAND OH 44115

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SHERWIN WILLIAMS CO [ SHW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
10/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$331.37	10/20/2025		A		47,630		(1)	10/19/2035	Common Stock	47,630	$0	47,630(1)	D

Explanation of Responses:

1. These options were granted on October 20, 2025, pursuant to the terms of a stock option agreement under the 2025 Equity and Incentive Compensation Plan. The options vest annually in three substantially equal installments commencing October 20, 2026, subject to vesting conditions.

Remarks:

	Stephen J. Perisutti, Attorney-in-fact	10/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Sherwin-Williams (SHW) report in this Form 4?

A grant of 47,630 employee stock options to the President & CEO and director on October 20, 2025.

What is the exercise price of the SHW options granted?

The options have an exercise price of $331.37 per share.

How do the SHW CEO’s options vest?

They vest in three substantially equal annual installments beginning October 20, 2026, subject to vesting conditions.

When do these Sherwin-Williams options expire?

They expire on October 19, 2035.

Were any SHW shares bought or sold on the open market?

No. The report lists an option grant; no open-market stock sales or purchases were reported.

Under which plan were the SHW options granted?

The grant was made under the 2025 Equity and Incentive Compensation Plan.